ConductScience.org, home

Paper8554206

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

Turner R and 2 others. Ann Intern Med, 1996. Cited by 379 papers, by iCite.

Cite this record

ConductScience Library. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Papers, record 8554206. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8554206

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.
PubMed
Journal
Ann Intern Med
PubMed
Year
1996
PubMed
Publication types
Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
379
iCite
Relative citation ratio, by iCite
12.4
iCite
Revised in PubMed
2026-02-05
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Turner RR
2Cull CC
3Holman RR

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood GlucoseMajor topic
Diabetes Mellitus, Type 2Major topic
Diabetic AngiopathiesMajor topic
Hypoglycemic AgentsMajor topic
Adult
Body Weight
Combined Modality Therapy
Fasting
Female
Follow-Up Studies
Glycated Hemoglobin
Humans
Hypoglycemia
Islets of Langerhans
Male
Middle Aged
Prospective Studies
United Kingdom

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03540758Regulation of Endogenous Glucose Production by Central KATP ChannelsBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by112

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 379 citations.

PMIDTitleJournalYearIn PapersSource
42207790One year of hyperglycemia in the Ins2Akita mouse does not impart changes in retinal vascular patterning.PLoS One2026https://conductscience.org/library/papers/42207790PubMed
40770322
Model-based estimation of the generalized impact fraction (GIF) and population attributable fraction (PAF) for interventions targeting risk factors affecting the five-year risk of diabetic retinopathy.
BMC Public Health2025https://conductscience.org/library/papers/40770322PubMed
40570536High rate of complications in a real-world cohort of youth with T2D: a multicenter analysis.J Diabetes Complications2025https://conductscience.org/library/papers/40570536PubMed
40140909Rising tide: the growing global burden and inequalities of early-onset type 2 diabetes among youths aged 15-34 years (1990-2021).Diabetol Metab Syndr2025https://conductscience.org/library/papers/40140909PubMed
39871817Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review.Diabetes Obes Metab2025https://conductscience.org/library/papers/39871817PubMed
39061960Novel Therapeutics for Type 2 Diabetes Mellitus-A Look at the Past Decade and a Glimpse into the Future.Biomedicines2024https://conductscience.org/library/papers/39061960PubMed
38867845Once-weekly insulin icodec versus once-daily long-acting insulins for type 2 diabetes mellitus: Systematic review and meta-analysis.Metabol Open2024https://conductscience.org/library/papers/38867845PubMed
38837240Metformin for preventing the progression of chronic kidney disease.Cochrane Database Syst Rev2024https://conductscience.org/library/papers/38837240PubMed
37789322Zingiber officinale rhizome extracts mediated ni nanoparticles and its promising biomedical and environmental applications.BMC Complement Med Ther2023https://conductscience.org/library/papers/37789322PubMed
36815723Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev2023https://conductscience.org/library/papers/36815723PubMed
36561089How a New Understanding of Drug or Drug Class Pharmacology Often Drives Drug Development: A Conversation with Steven E. Nissen, MD.Methodist Debakey Cardiovasc J2022https://conductscience.org/library/papers/36561089PubMed
36510180Attrition and social vulnerability during 2-year-long structured care in type 2 diabetes, the ERMIES randomized controlled trial.BMC Endocr Disord2022https://conductscience.org/library/papers/36510180PubMed
36478472Increased Advanced Glycation Endproducts, Stiffness, and Hardness in Iliac Crest Bone From Postmenopausal Women With Type 2 Diabetes Mellitus on Insulin.J Bone Miner Res2023https://conductscience.org/library/papers/36478472PubMed
36341847A randomized controlled trial to test the efficacy of a diabetes behavioral intervention to prevent memory decline in older blacks/African Americans with diabetes and mild cognitive impairment.Contemp Clin Trials2022https://conductscience.org/library/papers/36341847PubMed
35942330Impact of the Fasting Plasma Glucose Titration Target on the Success of Basal Insulin Titration in Insulin-Naïve Patients with Type 2 Diabetes: A Systematic Analysis.J Diabetes Res2022https://conductscience.org/library/papers/35942330PubMed
35058601Association of anthropometric parameters as a risk factor for development of diabetic retinopathy in patients with diabetes mellitus.Eye (Lond)2023https://conductscience.org/library/papers/35058601PubMed
34991585The many faces of diabetes. Is there a need for re-classification? A narrative review.BMC Endocr Disord2022https://conductscience.org/library/papers/34991585PubMed
34189680Beyond hemoglobin A1c: a videographic analysis of conversations about quality of life and treatment burden during clinical encounters for diabetes care.Endocrine2021https://conductscience.org/library/papers/34189680PubMed
32827219Reduction in saturated fat intake for cardiovascular disease.Cochrane Database Syst Rev2020https://conductscience.org/library/papers/32827219PubMed
32476140Effects of total fat intake on body fatness in adults.Cochrane Database Syst Rev2020https://conductscience.org/library/papers/32476140PubMed

See all 112 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8554206

GET https://conductscience.org/api/papers/v1/8554206/cited_by?page=2